Literature DB >> 29928377

MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9.

Sida Liu1, Han Dong2, Hui Dai3, Danwei Liu4, Zhihao Wang2.   

Abstract

Micro (mi)RNAs are small, evolutionarily conserved and endogenous noncoding RNA molecules between 19 and 24 nucleotides in length. The potential roles of miRNAs in the carcinogenesis and progression of non-small cell lung cancer (NSCLC) have been studied previously. In the present study, it was revealed that miRNA-216b (miR-216b) expression was lower in NSCLC tissue and cell lines compared with that in adjacent healthy lung tissue samples and the normal bronchial epithelial 16HBE cell line, respectively. The ectopic expression of miR-216b inhibited the proliferation and invasion of NSCLC cells in vitro. SRY-Box 9 (SOX9) was identified as a direct target of miR-216b in NSCLC. In addition, SOX9 small interfering RNA was able to mimic the effects of miR-216b overexpression on cell proliferation and invasion in NSCLC. Therefore, the data reported in the present study demonstrate that miR-216b is an important tumor suppressor in NSCLC. These data may contribute to the understanding of the molecular mechanism underlying the carcinogenesis and progression of NSCLC, and provide novel therapies for patients with NSCLC.

Entities:  

Keywords:  SRY-Box 9; invasion; microRNA-216b; non-small-cell lung cancer; proliferation

Year:  2018        PMID: 29928377      PMCID: PMC6004665          DOI: 10.3892/ol.2018.8573

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  48 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.

Authors:  Mattia Boeri; Ugo Pastorino; Gabriella Sozzi
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

3.  MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.

Authors:  Ying Wang; Po Xu; Jun Yao; Ruina Yang; Zhenguo Shi; Xiaojuan Zhu; Xiaoshan Feng; Shegan Gao
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

4.  Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.

Authors:  J Y Shao; X M Huang; X J Yu; L X Huang; Q L Wu; J C Xia; H Y Wang; Q S Feng; Z F Ren; I Ernberg; L F Hu; Y X Zeng
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

5.  [miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].

Authors:  Min Deng; Ji-fang Liu; Yi-xue Gu; Guo-pei Zheng; Zhi-min He
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2013-09

6.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

7.  Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.

Authors:  Rusty L Montgomery; Thomas G Hullinger; Hillary M Semus; Brent A Dickinson; Anita G Seto; Joshua M Lynch; Christianna Stack; Paul A Latimer; Eric N Olson; Eva van Rooij
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

Review 8.  The role of MET receptor tyrosine kinase in non-small cell lung cancer and clinical development of targeted anti-MET agents.

Authors:  Kyle W Robinson; Alan B Sandler
Journal:  Oncologist       Date:  2013-01-23

Review 9.  MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis.

Authors:  Ivan Vannini; Francesca Fanini; Muller Fabbri
Journal:  Clin Biochem       Date:  2013-02-08       Impact factor: 3.281

10.  MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.

Authors:  Jingyuan Li; Lijuan Wang; Zongzhi Liu; Chao Zu; Fanfan Xing; Pei Yang; Yongkang Yang; Xiaoqian Dang; Kunzheng Wang
Journal:  Oncotarget       Date:  2015-09-22
View more
  11 in total

1.  miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer.

Authors:  Qing-Qing Tian; Jing Xia; Xin Zhang; Bao-Qin Gao; Wei Wang
Journal:  Cancer Manag Res       Date:  2020-07-14       Impact factor: 3.989

2.  miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.

Authors:  Hao Zhang; Zhenya Zhang; Lili Gao; Zhengdong Qiao; Minghua Yu; Bo Yu; Tao Yang
Journal:  Onco Targets Ther       Date:  2019-03-22       Impact factor: 4.147

3.  Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.

Authors:  Weimin Ren; Wencai Guan; Jinguo Zhang; Fanchen Wang; Guoxiong Xu
Journal:  Aging (Albany NY)       Date:  2019-04-14       Impact factor: 5.682

4.  SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.

Authors:  Jing-Qiang Huang; Fa-Kai Wei; Xiu-Li Xu; Shi-Xing Ye; Jun-Wei Song; Pei-Kun Ding; Jing Zhu; He-Feng Li; Xin-Ping Luo; Hui Gong; Li Su; Lin Yang; Li-Yun Gong
Journal:  J Transl Med       Date:  2019-05-06       Impact factor: 5.531

5.  MicroRNA-30a regulates chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells through targeting Sox9.

Authors:  Hongqi Zhang; Yunjia Wang; Guanteng Yang; Honggui Yu; Zhenhai Zhou; Mingxing Tang
Journal:  Exp Ther Med       Date:  2019-10-30       Impact factor: 2.447

6.  The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.

Authors:  Mingfei Zuo; Lan Yao; Lijuan Wen; Jianfei Shen; Na Zhang; Tian Bai; Qicheng Huang
Journal:  World J Surg Oncol       Date:  2021-09-01       Impact factor: 2.754

7.  Effects and Mechanism of Zishen Jiangtang Pill on Diabetic Osteoporosis Rats Based on Proteomic Analysis.

Authors:  Shufang Chu; Deliang Liu; Hengxia Zhao; Mumin Shao; Xuemei Liu; Xin Qu; Zengying Li; Jinhua Li; Huilin Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-24       Impact factor: 2.629

Review 8.  [MicroRNA and Lung Cancer: A Mini Review].

Authors:  Lei Tuo; Xiaoshuai Chu; Sha Sha; Xun Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-09-20

9.  MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.

Authors:  Zhenyuan Qian; Lijie Gong; Yiping Mou; Yong Han; Shusen Zheng
Journal:  Oncol Rep       Date:  2019-09-12       Impact factor: 3.906

10.  Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1.

Authors:  Xiaobing Cai; Wenyu Xiao; Juexin Shen; Hui Lian; Yi Lu; Xianmiao Liu; Jisheng Gu
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.